BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS

This adverse event was reported 13 times

These drugs are most commonly taken by patients reporting BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS:

# Drug Count
0 PANTOPRAZOLE 13
1 ACETAMINOPHEN 12
2 ACETAMINOPHEN 500MG 12
3 ACETAMINOPHEN TABLET EXTENDED RELEASE 12
4 ALBUTEROL SULFATE 12
5 APIXABAN 12
6 BISOPROLOL FUMARATE 12
7 DIAZEPAM 12
8 DIAZEPAM ORAL 12
9 DIAZEPAM ORAL SOLUTION (CONCENTRATE) 12
See all common drugs associated with BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS

BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MICAFUNGIN SODIUM 11 0.0017
1 ERYTHROMYCIN ETHYLSUCCINATE 1 0.0016
2 REPAGLINIDE 12 0.0016
3 HEPARIN SODIUM 12 0.0008
4 ERYTHROMYCIN 12 0.0006
5 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 12 0.0006
6 PIPERACILLIN AND TAZOBACTAM 6 0.0005
7 PIPERACILLIN SODIUM,TAZOBACTAM SODIUM 12 0.0004
8 MIDAZOLAM HYDROCHLORIDE 12 0.0004
9 LINEZOLID 12 0.0004
See all drugs enriched for association with BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS

BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Somatostatin Analog [EPC] 11 0.0016
1 Glinide [EPC] 12 0.0013
2 Echinocandin Antifungal [EPC] 11 0.0013
3 Oxazolidinone Antibacterial [EPC] 12 0.0004
4 Penem Antibacterial [EPC] 12 0.0004
5 General Anesthetic [EPC] 12 0.0003
6 Insulin [EPC] 10 0.0002
7 Macrolide Antimicrobial [EPC] 11 0.0002
8 Factor Xa Inhibitor [EPC] 12 0.0000
9 Opioid Agonist [EPC] 11 0.0000
See all drug classes enriched for association with BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS